Serine‐227 in the N‐terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma

RSK2 is a serine/threonine kinase downstream signaling mediator in the RAS/ERK signaling pathway and may be a therapeutic target in mantle cell lymphoma (MCL), an almost incurable disease subtype of non‐Hodgkin lymphoma. In this study, serine‐227 (RSK2(Ser227)) in the N‐terminal kinase domain (NTKD)...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumura‐Kimoto, Yayoi, Tsukamoto, Taku, Shimura, Yuji, Chinen, Yoshiaki, Tanba, Kazuna, Kuwahara‐Ota, Saeko, Fujibayashi, Yuto, Nishiyama, Daichi, Isa, Reiko, Yamaguchi, Junko, Kawaji‐Kanayama, Yuka, Kobayashi, Tsutomu, Horiike, Shigeo, Taniwaki, Masafumi, Kuroda, Junya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367644/
https://www.ncbi.nlm.nih.gov/pubmed/32420699
http://dx.doi.org/10.1002/cam4.3136

Ejemplares similares

Ejemplares similares